This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Fat Profits: How Investors Can Capitalize on Obesity Battle




By Jeff Cox, CNBC.com Senior Writer

NEW YORK ( CNBC) -- More than one-third of Americas are considered obese, and investors looking to capitalize on the battle to reverse the trend could find themselves well-fed.

Getting financially fat off the "globesity" fight to help overweight Americans is the latest investing thesis from Bank of America Merrill Lynch, which believes global efforts to attack the problem will provide opportunities to make money.

The firm divides its recommendations across four sectors and more than 50 stocks that will benefit, particularly for those investors with longer time frames.

"Although it is difficult to accurately gauge the link between such exposure and share price performance, ... we still consider fighting obesity exposure an important and positive point to track, given that obesity is a sustainability megatrend with a 25-50 year lifespan," BofA equity analyst Sarbjit Nahal said in an analysis for clients.

More from CNBC
JPMorgan's Whale Tale: More To Come?
How Will the Drought Affect Consumer Food Prices?
Wall Street's Secret Weapon for Getting an Edge

Some 1.4 billion of the world's 7 billion residents are considered overweight, and 500 million are classified as obese, according to the World Health Organization.

In the U.S., the Centers for Disease Control and Prevention says 35.7% of the population is obese, with nine states having more than a 30% rate and no state under 20%.

Medical costs associated with obesity are currently around $150 billion a year, with those numbers only expected to climb.

Such statistics help make the case for the BoA fat-fighting play.

"This will require a 25-50 year 'systems perspective,' in our view, targeting multiple stakeholders and environments, going beyond health to include the food and beverage industry, schools, work environments, insurers tackling sedentary lifestyles and encouraging increasing physical activity," Nahal said.

The firm breaks its recommendations into four sectors: pharmaceuticals and health care; food; commercial weight loss, diet management and nutrition; and sports apparel and equipment.

Among the long list of stocks BofA recommends: The pharma plays include Allergan (AGN) and St. Jude Medical (STJ); while in food familiar names include ConAgra (CAG), Heinz (HNZ) and Panera (PNRA).

The four diet management and nutrition stocks on the list include Herbalife (HLF) and Weight Watchers (WTW), while the sports apparel and equipment space includes Under Armour (UA), Dick's (DKS) and Nike (NKE).

"We view Medicare's adoption of obesity counseling onto coverage as a significant step in recognizing obesity as a legitimate health concern," Nahal said.

Health care stocks have been solid performers in 2012, ranking fifth of the 10 sectors on the Standard & Poor's 500 with a 9.9% gain, though returns have slowed considerably in the second quarter.



--Written by Jeff Cox at CNBC

CNBC is a world leader in business news, providing real-time financial market coverage and business information.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs